| [1] |
Yan JB, Xu HP, Xiong C, et al. Rapid and reliable detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations in Han Chinese using high-resolution melting analysis[J]. 2010, 12(3): 305–311.
|
| [2] |
邓春，邓兵，余加林，等. 新生儿葡萄糖6-磷酸脱氢酶缺陷症基因突变分析与临床[J]. 中华围产医学杂志，2004，7(5): 283–285.
|
| [3] |
陈女冬，陈和平，王女燕，等. "地贫"合并G6PD缺陷症G6PD活性的实验研究[J]. 中国优生与遗传杂志，2006, 14(5): 28–30.
|
| [4] |
周宇芳，邓毅，张国风. G-6-PD缺陷致新生儿高胆红素血症光疗后副效应观察[J]．中国小儿血液，2002, 7(3): 110–112.
|
| [5] |
钟柏茂，徐晓娟．光疗对G-6-PD缺乏新生儿溶血的效应[J]．中国小儿血液，2005, 10(2): 77–79.
|
| [6] |
苏珊珊，罗成贵，黄永月．G-6-PD缺乏症与新生儿高胆红素血症的关系[J]. 广西医学，2005, 27(8): 1214–1215.
|
| [7] |
郑惠童，刘莎，程冰梅. 新生儿葡萄糖6-磷酸脱氢酶缺陷症发生高胆红素血症的围产因素[J]．中华围产医学杂志，2001, 4(2): 118–119.
|
| [8] |
薛辛东，杜立中，毛萌，主编．儿科学. 2版[M]．北京：人民卫生出版社，2011：374–376.
|
| [9] |
麦友刚，郑念时. 新生儿溶血性黄疸患者过氧化状况的初步探讨[J]．新生儿科杂志，1997, 12(4): 145–146.
|
| [10] |
陈光辉，刘东成，陈慧，等. 光疗对葡萄糖-6-磷酸脱氢酶活性不同的高胆红素血症新生儿抗氧化能力的影响[J]．中国基层医药，2006, 13(7): 1142–1143.
|
| [11] |
Steiner LA, Gallagher PG. Erythrocyte disorders in the perinatal period in adverse pregnancy outcome and the fetus/neonate[J]. Semin Perinatol, 2007, 31(4): 254–261.
|
| [12] |
邵肖梅，叶鸿瑁，丘小汕，主编. 实用新生儿学. 4版[M]. 北京：人民卫生出版社，2011：611–615.
|
| [13] |
花少栋，封志纯. 新生儿黄疸的研究进展[J]. 中国小儿急救医学，2011, 18(1): 74–78.
|
| [14] |
Benaron DA, Bowen FW. Variation of initial serum bilirubin rise in newborn infants with type of illness[J]. Lancet, 1991, 338(8759): 78–81.
|
| [15] |
Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance[J]. Science, 1987, 235(4792): 1043–1046.
|
| [16] |
Nakagami T, Toyomura K, Kinoshita T, et al.A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin[J]. Biochim Biophys Acta, 1993, 1158(2): 189–193.
|
| [17] |
Clark JE, Foresti R, Sarathchandra P, et al.Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction[J]. Am J Physiol Heart Circ Physiol, 2000, 278(2): H643–H651.
|
| [18] |
Wang HD, Yamaya M, Okinaga S, et al. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats[J]. Am J Respir Crit Care Med, 2002, 165(3): 406–411.
|
| [19] |
Polte T, Hemmerle A, Berndt G, et al. Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and hemeoxygenase-1[J]. Free Radic Biol Med, 2002, 32(1): 56–63.
|
| [20] |
Mreihil K, McDonagh AF, Nakstad B, et al. Early isomerization of bilirubin in phototherapy of neonatal jaundice[J]. Pediatr Res, 2010, 67(6): 656–659.
|
| [21] |
Barak M, Berger I, Dollberg S, et al.When should phototherapy be stopped? A pilot study comparing two targets of serum bilirubin concentration[J]. Acta Paediatr, 2009, 98(2): 277–281.
|
| [22] |
Kappas A, Drummond GS, Valaes T. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns[J]. Pediatrics, 2001, 108(1): 25–30.
|